The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte JIA-HE LI and JIE ZHANG
__________
Appeal No. 2005-1516
Application No. 09/182,645
__________
ON BRIEF
__________
Before ELLIS, MILLS, and GRIMES, Administrative Patent Judges.
MILLS, Administrative Patent Judge.
DECISION ON APPEAL
This is a decision on appeal under 35 U.S.C. §134 from the examiner's final
rejection of claims 46-49 which are all of the claims on appeal1 in this application.
These claims read as follows:
46. A method of treating neural or cardiac tissue damage resulting from a disease or
condition in a mammal in need thereof, comprising administering to said mammal a
therapeutically effective amount of an inhibitor of poly(ADP-ribose) glucohydrolase.
47. The method of claim 46, wherein the disease or condition is ischemia, reperfusion
injury, neurodegenerative disease, neurological disease, head trauma, cardiovascular
disease, heart attack, and vascular stroke.
1 Claims 1-25, 28-31 and 35-38 have been withdrawn from consideration by the
examiner but are still pending. Claims 26-27, 32-34 and 39-45 are cancelled.
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 Next
Last modified: November 3, 2007